SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/12/19 Biolase, Inc 10-Q 9/30/19 86:10M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 792K 7: EX-4.8 Instrument Defining the Rights of Security Holders HTML 95K 2: EX-10.5 Material Contract HTML 55K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 6: EX-32.2 Certification -- §906 - SOA'02 HTML 27K 54: R1 Document and Entity Information HTML 78K 32: R2 Consolidated Balance Sheets (Unaudited) HTML 111K 39: R3 Consolidated Balance Sheets (Unaudited) HTML 47K (Parenthetical) 83: R4 Consolidated Statements Of Operations And HTML 97K Comprehensive Loss (Unaudited) 52: R5 Consolidated Statements of Stockholders' (Deficit) HTML 58K Equity (Unaudited) 31: R6 Consolidated Statements Of Cash Flows (Unaudited) HTML 134K 38: R7 Description of Business and Basis of Presentation HTML 42K 81: R8 Summary of Significant Accounting Policies HTML 40K 55: R9 Revenue Recognition HTML 215K 48: R10 Stockholders' (Deficit) Equity HTML 300K 21: R11 Inventory HTML 46K 64: R12 Property, Plant, and Equipment HTML 67K 73: R13 Intangible Assets and Goodwill HTML 29K 47: R14 Accrued Liabilities HTML 117K 20: R15 Debt HTML 103K 63: R16 Leases HTML 74K 72: R17 Commitments and Contingencies HTML 34K 46: R18 Segment Information HTML 75K 22: R19 Concentrations HTML 114K 50: R20 Income Taxes HTML 31K 79: R21 Subsequent Events HTML 36K 34: R22 Summary of Significant Accounting Policies HTML 77K (Policies) 24: R23 Revenue Recognition (Tables) HTML 296K 49: R24 Stockholders' (Deficit) Equity (Tables) HTML 304K 78: R25 Inventory (Tables) HTML 47K 33: R26 Property, Plant, and Equipment (Tables) HTML 66K 23: R27 Accrued Liabilities (Tables) HTML 118K 51: R28 Debt (Tables) HTML 79K 77: R29 Leases (Tables) HTML 75K 74: R30 Segment Information (Tables) HTML 76K 66: R31 Concentrations (Tables) HTML 166K 18: R32 Description of Business and Basis of Presentation HTML 69K - Additional Information (Detail) 44: R33 Summary of Significant Accounting Policies - HTML 36K Additional Information (Detail) 75: R34 Revenue Recognition - Additional Information HTML 38K (Detail) 67: R35 Summary of Opening and Closing Balances of HTML 36K Contract Liabilities (Detail) 19: R36 Summary of Disaggregation of Revenues Related to HTML 32K Geographic Areas (Detail) 45: R37 Summary of Revenues Disaggregated by Timing of HTML 33K Goods and Services Transferred (Detail) 76: R38 Summary of Sales by End Market (Detail) HTML 33K 65: R39 Summary of Percentages of Sales by Product line HTML 40K (Detail) 80: R40 Stockholders' (Deficit) Equity - Additional HTML 84K Information (Detail) 56: R41 Classification of Compensation Expense Associated HTML 38K with Share-Based Payments (Detail) 29: R42 Assumptions Used in Estimating Fair Value of Stock HTML 34K Options Granted (Detail) 40: R43 Summary of Option Activity (Detail) HTML 65K 82: R44 Summary of Unvested Stock Option Activity (Detail) HTML 47K 57: R45 Cash Proceeds Along with Fair Value Disclosures HTML 33K Related to Grants, Exercises and Vested Options (Detail) 30: R46 Summary of Unvested Restricted Stock Units HTML 50K (Detail) 41: R47 Summary of Warrant Activity (Detail) HTML 43K 84: R48 Components of Inventory (Detail) HTML 35K 53: R49 Inventory - Additional Information (Detail) HTML 28K 61: R50 Summary of Property, Plant, and Equipment (Detail) HTML 49K 70: R51 Property, Plant, and Equipment - Additional HTML 28K Information (Detail) 43: R52 Intangible Assets and Goodwill - Additional HTML 34K Information (Detail) 17: R53 Components of Accrued Liabilities (Detail) HTML 52K 60: R54 Changes in Initial Product Warranty Accrual and HTML 41K Expenses Under Initial and Extended Warranties (Detail) 69: R55 Accrued Liabilities - Additional Information HTML 33K (Detail) 42: R56 Debt - Summary of Principal Outstanding and HTML 33K Unamortized Discount (Detail) 16: R57 Debt - Additional Information (Detail) HTML 209K 62: R58 Debt - Summary of Future Minimum Principal and HTML 49K Interest Payments (Detail) 68: R59 Leases - Additional Information (Detail) HTML 59K 37: R60 Leases - Information related to Right-of-use HTML 34K Assets and Liabilities (Detail) 27: R61 Leases - Schedule of Maturities of Lease HTML 39K Liabilities (Detail) 59: R62 Leases - Future Minimum Rental Commitments Under HTML 35K Lease Agreements (Detail) 86: R63 Commitments and Contingencies - Additional HTML 56K Information (Detail) 36: R64 Segment Information - Additional Information HTML 39K (Detail) 26: R65 Summary of Net Revenue by Geographic Location HTML 32K (Detail) 58: R66 Summary of Property, Plant and Equipment by HTML 33K Geographic Location (Detail) 85: R67 Concentrations - Summary of Net Revenue from HTML 51K Various Products (Detail) 35: R68 Concentrations - Additional Information (Detail) HTML 41K 28: R69 Income Taxes - Additional Information (Detail) HTML 37K 15: R70 Subsequent Events - Additional Information HTML 88K (Detail) 14: XML IDEA XML File -- Filing Summary XML 153K 71: EXCEL IDEA Workbook of Financial Reports XLSX 91K 8: EX-101.INS XBRL Instance -- biol-20190930 XML 2.79M 10: EX-101.CAL XBRL Calculations -- biol-20190930_cal XML 170K 11: EX-101.DEF XBRL Definitions -- biol-20190930_def XML 583K 12: EX-101.LAB XBRL Labels -- biol-20190930_lab XML 1.39M 13: EX-101.PRE XBRL Presentations -- biol-20190930_pre XML 1.06M 9: EX-101.SCH XBRL Schema -- biol-20190930 XSD 215K 25: ZIP XBRL Zipped Folder -- 0001564590-19-042402-xbrl Zip 178K
Download this zipped .zip folder | |
Files: | biol-20190930.xml biol-20190930.xsd biol-20190930_cal.xml biol-20190930_def.xml biol-20190930_lab.xml biol-20190930_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/03/23 Biolase, Inc. S-1/A 6:1M Donnelley … Solutions/FA 12/12/22 Biolase, Inc. S-1/A 7:1.1M Donnelley … Solutions/FA 11/22/22 Biolase, Inc. S-1 3:655K Donnelley … Solutions/FA 3/17/22 Biolase, Inc. 10-K 12/31/21 88:18M Donnelley … Solutions/FA 11/10/21 Biolase, Inc. 10-Q 9/30/21 84:13M Donnelley … Solutions/FA 8/13/21 Biolase, Inc. 10-Q 6/30/21 80:12M Donnelley … Solutions/FA 5/13/21 Biolase, Inc. 10-Q 3/31/21 81:9.4M Donnelley … Solutions/FA 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA 11/13/20 Biolase, Inc. 10-Q 9/30/20 81:11M ActiveDisclosure/FA 8/14/20 Biolase, Inc. 10-Q 6/30/20 89:12M ActiveDisclosure/FA |